Cancer

Multi-Analyte Genomics & Data

Implement Multi-Analyte Genomic Precision Oncology In Practice

Cancer Breakthroughs Summit 2.0

https://drive.google.com/file/d/1UEHQLiVe1UWWIF1X3heFU1sx8FKAjRzT/view?usp=drive_link

<h6><b>Nasha Winters, ND, FABNO</b></h6>
<span style="font-weight: 400;">Hello, everybody. I'm very excited about our next guest today. Dr. Vineet Datta from, well, the Datar world. Don't get those too confused. He is separate from the company's namesake. But this man, by no means, is someone who sits back in the shadows quietly. I have been blown away by what I've learned from him over the last few years in this industry, and I'm excited to share all this with you. I'm a clinician who's been looking for tools to better lead a clinical decision-making process for my patients, especially those who have come to the end of the line. I've tried a lot of different products, testing them on the market over many years. and watched many of these companies come and go. What I've been excited about with Datar is that they're here. They're not slowing down. What they're bringing to the world is changing. The world of especially stage three and four oncology outcomes. Dr. Datta, thank you so much for being with us today. Tell us a little bit about you and your company, and then we'll dive into some interesting conversation.</span>

https://d1tnc8rqovg0h0.cloudfront.net/2024+Summits/Cancer+Breakthroughs+2.0+Summit/Transcripts/2024_CBS_Vineet+Datta%2C+MD+Transcript+File.pdf

<p>Leading professional excellence in the field of healthcare research, delivery of innovative onco-genomic services and integrated medical service solutions.</p>


Vineet Datta

Vineet Datta, MD

<p>Dr. Nasha Winters is a global healthcare authority and best-selling author in integrative cancer care and research consulting with physicians around the world. She has educated hundreds of professionals in the clinical use of mistletoe, and has created robust educational programs for both healthcare institutions and the public on incorporating vetted integrative therapies in cancer care to enhance outcomes. Dr. Winters is currently focused on opening a comprehensive metabolic oncology hospital and research institute in the US where the best that standard of care has to offer and the most advanced integrative therapies will be offered. This facility will be in a residential setting on a gorgeous campus against a backdrop of regenerative farming, EMF mitigation and retreat, as well as state of the art medical technology and data collection and evaluation to improve patient outcomes.</p>


Implement Multi-Analyte Genomic Precision Oncology In Practice

Nasha Winters, ND, FABNO

Vineet Datta, MD

Summary

Content Provided By

Nasha Winters, ND, FABNO

Guest Experts

Vineet Datta, MD